Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aminoethyl nitrate is a small molecule organic nitrate ester formed by the condensation of ethanolamine and nitric acid. It acts as a vasodilator by generating nitric oxide (NO) upon metabolism, leading to relaxation of vascular smooth muscle and subsequent reduction in blood pressure. This mechanism underlies its use in the treatment of angina pectoris and ischemic heart disease. Unlike many other organic nitrates, aminoethyl nitrate has been shown to induce potent vasorelaxation without causing mitochondrial oxidative stress or endothelial dysfunction, and does not exhibit cross-tolerance with nitroglycerin or acetylcholine. Its unique pharmacological profile makes it an investigational candidate for cardiovascular therapy[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aminoethyl nitrate.